ClinicalTrials.govpublic full text
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
recurrent lung non-small cell carcinoma, stage iv lung cancer ajcc v8
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 127580
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.